Your AI-Trained Oncology Knowledge Connection!

Elgene Lim, MBBS, FRACP, PhD

home / authors / elgene-lim-mbbs-fracp-phd

Articles

8 TiP Randomized, Multicenter, Phase 3 Study to Evaluate the Combination of Enobosarm and Abemaciclib Compared With Estrogen-Blocking Agent for the Second-Line Treatment of AR+, ER+, HER2– Metastatic Breast Cancer in Patients Who Have Previously Received Palbociclib and an Estrogen-Blocking Agent Combination Therapy

Elgene Lim, MBBS, FRACP, PhD;Adam M. Brufsky, MD, PhD;Hope S. Rugo, MD;Charles L. Vogel, MD, FACP;Joyce A. O’Shaughnessy;Robert H. Getzenberg;K. Gary Barnette;Domingo Rodriguez;Mitchell Steiner;Hannah M. Linden, MD

April 18th 2022

Updates on the Management of Breast Cancer Brain Metastases

Elgene Lim, MBBS, FRACP, PhD;Nancy U. Lin, MD

July 15th 2014

In this overview, we will review recent developments in the management of breast cancer brain metastases and current prospective trials of systemic therapies specifically for patients with breast cancer brain metastases, with a focus on novel pathway-specific therapies.

The Natural History of Hormone Receptor–Positive Breast Cancer

Elgene Lim, MBBS, FRACP, PhD;Otto Metzger-filho, MD;Eric P. Winer, MD

August 10th 2012

In this article, we describe the long natural history of HR+ breast cancer and review current research and clinical strategies to address this clinical challenge.

New Insights and Emerging Therapies for Breast Cancer Brain Metastases

Elgene Lim, MBBS, FRACP, PhD;Nancy U. Lin, MD

July 15th 2012

The diagnosis of central nervous system (CNS) recurrence is a much dreaded outcome among breast cancer patients, and its incidence varies with disease stage and cancer subtype.